Englewood Hospital
Englewood, New Jersey, 07631, United States
Location status: Recruiting
NCT Number: NCT06681818
the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Englewood, New Jersey, 07631, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
participants in this study will provide breath samples for carbon monoxide measurements pre and post liver resection
Time frame: measurements will be taken pre, then 4 hours and 24 hours post resection
patients will be asked to donate exhaled breath into a smokerlyzer device
Time frame: measurements will be taken pre, then 4 hours and 24 hours post resection
patients will be asked to donate exhaled breath into a smokerlyzer device
Time frame: one and three months after resection
CT liver volumetric studies
Time frame: one and three months post resection
serum protein, albumin, AST and ALT, alkaline phosphatase, and bilirubin level
Contact information is provided by the study sponsor or research team.
Englewood Hospital and Medical Center
Other
Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07312292
Adenocarcinoma, Carcinoma
Utrecht, Netherlands
View Trial DetailsNCT07314372
Adenocarcinoma, Carcinoma
Nanjing, Jiangsu, China
View Trial DetailsNCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT07479485
Adenocarcinoma, Carcinoma
Beijing, Beijing Municipality, China
View Trial Details